News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
The biomanufacturing viral detection and quantification market is driven by the increasing complexity of biologics, rising ...
Detailed price information for Castle Biosciences Inc (CSTL-Q) from The Globe and Mail including charting and trades.
Opinion
Independent.ie on MSNOpinion
Letters to the editor: Sinn Féin goes beyond satire by embracing subsidised comedy
Irish republicans have faced many charges over the years but no one has ever accused them of a sense of humour. It was funny then to hear that Aengus Ó Snodaigh, Sinn Féin’s spokesperson for Arts and ...
PFRDA consolidates and updates NPS Tier-I & II investment rules for non-government sectors, specifying asset classes, limits, and rating norms. Ensures risk management and fiduciary ...
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...
Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.
Life science firms collaborate to deliver faster, simpler, and more scalable targeted sequencing. REHOVOT, Israel, June 9, 2025 /PRNewswire/ -- Sequentify and Bio Molecular Systems (BMS) today ...
This repository contains the electronic protocol files for the for the simultaneous amplification and dual-indexing of up to 384 DNA libraries through automated liquid handling using the Hamilton NGS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results